BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Genetown

  Cold Medication Use In Children Less Than Two Years Old Can Lead To Adverse Effects, Even Death, Children’s Hospital Boston/Harvard Medical School Study

  June 2, 2008

   · 

  1 min read
• Leeds University Medics Solve An Ancient Riddle -- And Offer New Tool For Diagnosis

  June 2, 2008

   · 

  1 min read
• BioCapital

  FDA: Time For Asthma Patients To Get New Inhalers

  June 2, 2008

   · 

  1 min read
• Medicago, Inc. Updates Following its Annual and Special Meeting of Shareholders

  June 2, 2008

   · 

  1 min read
• Drug Development

  Hana Biosciences, Inc.’ Phase 2 Clinical Trial of Marqibo for Metastatic Uveal Melanoma Meets Clinical Response Criteria to Advance to Full Enrollment

  June 2, 2008

   · 

  6 min read
• GTx, Inc. Announces Webcast of Corporate Presentation at Goldman, Sachs & Co. 29th Annual Global Healthcare Conference

  June 2, 2008

   · 

  1 min read
• BioMidwest

  Bruker Daltonics Inc. Introduces Novel LC/GC Time-of-Flight Mass Spectrometer micrOTOF™ II for LC/MS and GC/MS on One System

  June 2, 2008

   · 

  1 min read
• Drug Development

  Novelos Therapeutics, Inc. Announces Presentation of Encouraging Results in Phase 2 Ovarian Cancer Trial at 2008 American Society of Clinical Oncology Meeting by MGH and Novelos Therapeutics, Inc./Harvard Cancer Centers

  June 2, 2008

   · 

  1 min read
• Drug Development

  Poniard Pharmaceuticals, Inc. Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer - Phase 2 Data To Be Presented Along With Updated Phase 1 Colorectal Cancer Data at

  June 2, 2008

   · 

  6 min read
• Business

  Roche Signs Exclusive Distribution Deal With DxS Ltd For K-RAS And EGFR Cancer Mutation Tests; Tests Identify Genetic Mutations That Can Affect Patient Response To Certain Cancer Drugs

  June 2, 2008

   · 

  4 min read